Publications by authors named "Alma Harish"

Background: Waning immunity after the coronavirus disease 2019 (COVID-19) vaccinations creates the constant need of boosters. Predicting individual responses to booster vaccines can help in its timely administration. We hypothesized that the humoral response to the first two doses of the BNT162b2 vaccine can predict the response to the booster vaccine.

View Article and Find Full Text PDF
Article Synopsis
  • A third dose of the BNT162b2 vaccine significantly boosts antibody levels in healthy individuals.
  • Antibody levels were monitored in healthcare workers over one year, showing a notable increase right after the third dose, followed by a gradual decline.
  • Despite the decline, antibody levels remained higher than those recorded after previous doses even six months later.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Alma Harish"

  • - Recent research by Alma Harish focuses on understanding the humoral response to COVID-19 vaccinations, particularly in healthcare workers, with the goal of predicting individual responses to booster doses to enable personalized vaccination strategies.
  • - One key study evaluates the long-term dynamics of antibody titers after three doses of the BNT162b2 vaccine, finding significant increases in antibody levels but raising concerns about the persistence of this response over time.
  • - Harish's research emphasizes the importance of individual variability in vaccine response and the need for tailored booster administration based on human immunological data, enhancing the effectiveness of vaccination campaigns against COVID-19.